West Pharmaceutical Services Other European countries — Net Sales remained flat by 0.0% to $112.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.0%, from $96.38M to $112.75M. Over 4 years (FY 2021 to FY 2025), Other European countries — Net Sales shows an upward trend with a 7.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful market expansion or higher demand for pharmaceutical components in these specific regions, while a decrease may signal competitive pressure or economic headwinds in those territories.
This metric represents the total revenue generated from customers located in European countries outside of the company's...
Peers in the medical device and pharmaceutical supply chain typically report regional revenue splits to highlight geographic concentration risk and growth opportunities.
wst_segment_other_european_countries_net_sales| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $341.30M | $359.20M | $388.10M | $385.50M | $451.00M |
| YoY Change | — | +5.2% | +8.0% | -0.7% | +17.0% |